Regenacy Pharmaceuticals

Waltham, United States

Regenacy Pharmaceuticals Provides Healthcare Services.

$9.3M raised

Aug 2022

Series B

Biotechnology Health Care Medical Service Industry Therapeutics

Top Investors

Taiwania Capital Management Corporation 3E Bioventures Viva Biotech Rivas Capital Yonjin Venture

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Regenacy Pharmaceuticals

How much funding has Regenacy Pharmaceuticals raised?

Regenacy Pharmaceuticals has raised $9.3M in total funding. The most recent round was Series B. The last funding was announced in August 2022.

Who are Regenacy Pharmaceuticals's investors?

Regenacy Pharmaceuticals's investors include Taiwania Capital Management Corporation, 3E Bioventures, Viva Biotech, Rivas Capital, Yonjin Venture.

Where is Regenacy Pharmaceuticals headquartered?

Regenacy Pharmaceuticals is headquartered in Waltham, United States.

What does Regenacy Pharmaceuticals do?

Regenacy Pharmaceuticals Provides Healthcare Services.

What stage is Regenacy Pharmaceuticals at?

Regenacy Pharmaceuticals is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 15, 2022.

MLA

"Regenacy Pharmaceuticals — Funding & Investors." VCBacked, August 15, 2022, https://www.vcbacked.co/company/regenacy-pharmaceuticals. Accessed July 1, 2026.

APA

VCBacked. (2022). Regenacy Pharmaceuticals — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/regenacy-pharmaceuticals

Wikipedia (cite web)

{{cite web |title=Regenacy Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/regenacy-pharmaceuticals |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 15, 2022.